{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:12:23Z","timestamp":1790817143317,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SRG\/2021\/002312"],"award-info":[{"award-number":["SRG\/2021\/002312"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2022\/000218"],"award-info":[{"award-number":["EEQ\/2022\/000218"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.livres.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:44:16Z","timestamp":1763444656000},"page":"286-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolites involvement in the growth and spread of liver cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"Anurag Kumar","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana Bharti","family":"Sonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepankar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1702-4888","authenticated-orcid":false,"given":"Nitin","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar","family":"Mahalingam Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.29498","article-title":"Projections of primary liver cancer to 2030 in 30 countries worldwide","volume":"67","author":"Valery","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.livres.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1874357901812010026","article-title":"Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma","volume":"12","author":"Petruzziello","year":"2018","journal-title":"Open Virol J"},{"key":"10.1016\/j.livres.2025.10.005_bib5","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.livres.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jceh.2014.02.155","article-title":"Risk factors for hepatocellular carcinoma in India","volume":"4","author":"Kar","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib7","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7314\/APJCP.2015.16.9.3595","article-title":"Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma","volume":"16","author":"Wang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.livres.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.livres.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/jcp.24352","article-title":"Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism","volume":"228","author":"Koupenova","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.livres.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13046-021-01968-w","article-title":"Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets","volume":"40","author":"Luo","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.livres.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/jhep.2001.22506","article-title":"Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non\u2013iron-related chronic liver disease","volume":"33","author":"Fracanzani","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/HEP.0000000000000962","article-title":"Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC","volume":"81","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.62476\/abes9s81","article-title":"Novel nanomaterials for hepatobiliary diseases treatment and future perspectives","volume":"9","author":"Huseynov","year":"2024","journal-title":"Adv Biol Earth Sci"},{"key":"10.1016\/j.livres.2025.10.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2024.106961","article-title":"Ultrastructural investigation of iron oxide nanoparticles accumulation in the liver of common carp (Cyprinus carpio Linnaeus, 1758)","volume":"272","author":"Hajiyeva","year":"2024","journal-title":"Aquat Toxicol"},{"key":"10.1016\/j.livres.2025.10.005_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.674786","article-title":"The potential application of magnetic nanoparticles for liver fibrosis theranostics","volume":"9","author":"Eftekhari","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.livres.2025.10.005_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.livres.2025.04.002","article-title":"Nanoparticle-based therapeutic strategies for chronic liver diseases: advances and insights","volume":"9","author":"Padmanaban","year":"2025","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-022-01320-5","article-title":"Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies","volume":"15","author":"Tian","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib21","first-page":"25","article-title":"Applications of nanobiomaterials in the therapy and imaging of acute liver failure","volume":"13","author":"Jin","year":"2020","journal-title":"Nanomicro Lett"},{"key":"10.1016\/j.livres.2025.10.005_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100159","article-title":"Nanoparticle drug delivery systems in hepatocellular carcinoma: a focus on targeting strategies and therapeutic applications","volume":"12","author":"Metkar","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.livres.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/17425247.2021.1828339","article-title":"Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery","volume":"18","author":"Majumder","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.livres.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2613.2001.iep178.x","article-title":"Hepatitis B virus and hepatocellular carcinoma","volume":"82","author":"Arbuthnot","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.livres.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14218\/JCTH.2017.00067","article-title":"Hepatitis C virus and hepatocellular carcinoma: a narrative review","volume":"6","author":"Axley","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4254\/wjh.v7.i5.777","article-title":"Hepatitis D and hepatocellular carcinoma","volume":"7","author":"Abbas","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2018-000260","article-title":"Alcohol and hepatocellular carcinoma","volume":"6","author":"Matsushita","year":"2019","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.livres.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.3390\/cancers13225844","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: from epidemiology to diagnostic approach","volume":"13","author":"Grgurevic","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2025.10.005_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/cells8080845","article-title":"Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)","volume":"8","author":"Drescher","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.livres.2025.10.005_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000343852","article-title":"From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence","volume":"2","author":"Ramakrishna","year":"2013","journal-title":"Liver Cancer"},{"key":"10.1016\/j.livres.2025.10.005_bib32","article-title":"Involvement of DNA damage response pathways in hepatocellular carcinoma","volume":"2014","author":"Yang","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.livres.2025.10.005_bib33","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/343555a0","article-title":"Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma","volume":"343","author":"Wang","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.livres.2025.10.005_bib35","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/hep4.1974","article-title":"Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: a national register study","volume":"6","author":"Duberg","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2025.10.005_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2525","article-title":"Biomarkers of transfusion transmitted occult hepatitis B virus infection: where are we and what next?","volume":"34","author":"Fu","year":"2024","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.livres.2025.10.005_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2025.10.005_bib38","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.05.048","article-title":"Long-term effects of hepatitis B immunization of infants in preventing liver cancer","volume":"151","author":"Chang","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.10.005_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.30823","article-title":"Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib40","series-title":"Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C","year":"2010"},{"key":"10.1016\/j.livres.2025.10.005_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jjco\/hyaa130","article-title":"Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018","volume":"50","author":"Sharma","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.dld.2023.01.153","article-title":"Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort","volume":"55","author":"Kondili","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2025.10.005_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13027-024-00606-2","article-title":"From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis","volume":"19","author":"Martineau","year":"2024","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.livres.2025.10.005_bib44","series-title":"Hepatitis C Viruses: Genomes and Molecular Biology","article-title":"HCV NS5A: a multifunctional regulator of cellular pathways and virus replication","author":"He","year":"2006"},{"key":"10.1016\/j.livres.2025.10.005_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhepr.2019.05.001","article-title":"The oncogenic role of hepatitis delta virus in hepatocellular carcinoma","volume":"1","author":"Puigveh\u00ed","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2025.10.005_bib46","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/jvh.13577","article-title":"Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: a systematic review and meta-analysis of longitudinal studies","volume":"28","author":"Kamal","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.livres.2025.10.005_bib47","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3390\/cancers16223723","article-title":"The changing face of hepatitis delta virus associated hepatocellular carcinoma","volume":"16","author":"Cardoso","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2025.10.005_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/liv.15253","article-title":"Hepatocellular carcinoma: the virus or the liver?","volume":"43","author":"Papatheodoridi","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2025.10.005_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-156-12-201206190-00004","article-title":"Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study","volume":"156","author":"Jepsen","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2025.10.005_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.11.045","article-title":"Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis","volume":"58","author":"Lin","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102584","article-title":"Ajazuddin. Metabolic dysfunction-associated steatotic liver disease (MASLD): exploring systemic impacts and innovative therapies","volume":"49","author":"Jain","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.livres.2025.10.005_bib52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/cancers16020259","article-title":"MASLD and the development of HCC: pathogenesis and therapeutic challenges","volume":"16","author":"Phoolchund","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2025.10.005_bib53","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.livres.2025.10.005_bib54","series-title":"StatPearls","article-title":"Nonalcoholic steatohepatitis (NASH)","author":"Sharma","year":"2023"},{"key":"10.1016\/j.livres.2025.10.005_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11418-017-1122-5","article-title":"Evodiamine ameliorates liver fibrosis in rats via TGF-\u03b21\/Smad signaling pathway","volume":"72","author":"Yang","year":"2018","journal-title":"J Nat Med"},{"key":"10.1016\/j.livres.2025.10.005_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/jhep.2001.25349","article-title":"The role of Smad3 in mediating mouse hepatic stellate cell activation","volume":"34","author":"Schnabl","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib60","article-title":"Global epidemiology of hepatocellular carcinoma","volume":"15","author":"Singh","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib61","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.10.005_bib62","first-page":"S3","article-title":"Primary biliary cholangitis: medical and specialty pharmacy management update","volume":"22","author":"Bowlus","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.livres.2025.10.005_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.34172\/mejdd.2024.371","article-title":"Simultaneous occurrence of Wilson\u2019s disease, autoimmune hepatitis, and hereditary hemochromatosis: a diagnostic challenge","volume":"16","author":"Fatemi","year":"2024","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.livres.2025.10.005_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.601710","article-title":"Etiology of hepatocellular carcinoma: special focus on fatty liver disease","volume":"10","author":"Suresh","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v9.i1.1","article-title":"Disease monitoring of hepatocellular carcinoma through metabolomics","volume":"9","author":"Fitian","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11759-z","article-title":"Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach","volume":"7","author":"Chang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2025.10.005_bib67","series-title":"Loss of Keratin 19 predisposes to the development of cholestatic liver disease","author":"Chen","year":"2016"},{"key":"10.1016\/j.livres.2025.10.005_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43066-021-00085-9","article-title":"The role of metabolomics in hepatocellular carcinoma","volume":"11","author":"Khalil","year":"2021","journal-title":"Egyptian Liver Journal"},{"key":"10.1016\/j.livres.2025.10.005_bib69","series-title":"Hepatocellular Carcinoma","article-title":"The role of lipids in hepatocellular carcinoma","author":"Hayes","year":"2019"},{"key":"10.1016\/j.livres.2025.10.005_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","article-title":"Pyruvate carboxylase and cancer progression","volume":"9","author":"Kiesel","year":"2021","journal-title":"Cancer Metab"},{"key":"10.1016\/j.livres.2025.10.005_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/cancers10030082","article-title":"The roles of protein tyrosine phosphatases in hepatocellular carcinoma","volume":"10","author":"Huang","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.livres.2025.10.005_bib72","first-page":"3103","article-title":"Diagnosis of hepatocellular carcinoma using a novel anti-glycocholic acid monoclonal antibody-based method","volume":"17","author":"Wu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.livres.2025.10.005_bib73","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/2211-5463.12511","article-title":"Arachidonic acid suppresses hepatic cell growth through ROS-mediated activation of transglutaminase","volume":"8","author":"Qin","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.livres.2025.10.005_bib74","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000271","article-title":"Liver Cancer\u2013specific serine protease inhibitor kazal is a potentially novel biomarker for the early detection of hepatocellular carcinoma","volume":"11","author":"Lu","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.livres.2025.10.005_bib75","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4103\/ejim.ejim_73_19","article-title":"Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy","volume":"31","author":"Elrabat","year":"2019","journal-title":"The Egyptian Journal of Internal Medicine"},{"key":"10.1016\/j.livres.2025.10.005_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102273","article-title":"The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Abolfathi","year":"2020","journal-title":"Compl Ther Med"},{"key":"10.1016\/j.livres.2025.10.005_bib77","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/hep4.1207","article-title":"L-carnitine suppresses loss of skeletal muscle mass in patients with liver cirrhosis","volume":"2","author":"Ohara","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2025.10.005_bib78","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/0016-5085(94)90024-8","article-title":"Overexpression of glutamine synthetase in human primary liver cancer","volume":"106","author":"Christa","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.10.005_bib79","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.livres.2025.10.005_bib80","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1940-6207.CAPR-11-0340","article-title":"Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells","volume":"4","author":"Ninomiya","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.livres.2025.10.005_bib81","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2019.10.026","article-title":"Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis","volume":"72","author":"Ding","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib82","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/cells9112491","article-title":"Methionine supplementation affects metabolism and reduces tumor aggressiveness in liver cancer cells","volume":"9","author":"Tripodi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2025.10.005_bib83","doi-asserted-by":"crossref","first-page":"11640","DOI":"10.1096\/fj.201901175R","article-title":"Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2025.10.005_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/608216","article-title":"Effects of oral L-carnitine on liver functions after transarterial chemoembolization in intermediate-stage HCC patients","volume":"2015","author":"Hassan","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.livres.2025.10.005_bib85","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/nu12071915","article-title":"Usefulness of carnitine supplementation for the complications of liver cirrhosis","volume":"12","author":"Hanai","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2025.10.005_bib86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.arcmed.2019.12.005","article-title":"Effect of L-carnitine supplementation on liver enzymes: a systematic review and meta-analysis of randomized controlled trials","volume":"51","author":"Askarpour","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.livres.2025.10.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120277","article-title":"Effect of l-carnitine supplementation on lead acetate-induced liver cell apoptosis and inflammation: role of caspase-3 and glycogen synthase kinase-3\u03b2 enzymes","volume":"291","author":"Abdel-Emam","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2025.10.005_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.etp.2007.02.009","article-title":"Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice","volume":"59","author":"Yapar","year":"2007","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.livres.2025.10.005_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000425","article-title":"Potential utility of L-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Lyu","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2025.10.005_bib90","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3904\/kjim.2021.338","article-title":"Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"37","author":"Yoon","year":"2022","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.livres.2025.10.005_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111181","article-title":"Branched-chain amino acids and L-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver","volume":"135","author":"Tamai","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2025.10.005_bib92","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acs.jmedchem.1c01605","article-title":"Identification of pyruvate carboxylase as the cellular target of natural bibenzyls with potent anticancer activity against hepatocellular carcinoma via metabolic reprogramming","volume":"65","author":"Sheng","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.livres.2025.10.005_bib93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1083\/jcb.201604085","article-title":"The importance of serine metabolism in cancer","volume":"214","author":"Mattaini","year":"2016","journal-title":"J Cell Biol"},{"key":"10.1016\/j.livres.2025.10.005_bib94","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2018.06.009","article-title":"Serine synthesis via PHGDH is essential for heme production in endothelial cells","volume":"28","author":"Vandekeere","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2025.10.005_bib95","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7555\/JBR.34.20190037","article-title":"Glutamate in cancers: from metabolism to signaling","volume":"34","author":"Yi","year":"2019","journal-title":"J Biomed Res"},{"key":"10.1016\/j.livres.2025.10.005_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-030-65768-0_2","article-title":"Glutamine metabolism in cancer","volume":"1311","author":"Li","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.livres.2025.10.005_bib97","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/nu12123717","article-title":"Essential amino acids and protein synthesis: insights into maximizing the muscle and whole-body response to feeding","volume":"12","author":"Church","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2025.10.005_bib98","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00702-014-1182-6","article-title":"Glutamate and its receptors in cancer","volume":"121","author":"Stepulak","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.livres.2025.10.005_bib99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.livres.2025.10.005_bib100","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted role of branched-chain amino acid metabolism in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.livres.2025.10.005_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched chain amino acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.livres.2025.10.005_bib102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fchem.2018.00243","article-title":"The human SLC7A5 (LAT1): the intriguing histidine\/large neutral amino acid transporter and its relevance to human health","volume":"6","author":"Scalise","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.livres.2025.10.005_bib103","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/s41598-025-87522-6","article-title":"Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy","volume":"15","author":"Jin","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2025.10.005_bib104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neures.2004.08.003","article-title":"System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells","volume":"50","author":"Kim","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.livres.2025.10.005_bib105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2017.01.009","article-title":"High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation","volume":"104","author":"Zhenyukh","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2025.10.005_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1615\/CritRevOncog.v17.i1.60","article-title":"Targeting PI3 kinase\/AKT\/mTOR signaling in cancer","volume":"17","author":"Sheppard","year":"2012","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.livres.2025.10.005_bib107","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/cells9112491","article-title":"Methionine supplementation affects metabolism and reduces tumor aggressiveness in liver cancer cells","volume":"9","author":"Tripodi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2025.10.005_bib108","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/biomedicines13051244","article-title":"New insights into the diagnosis and treatment of hepatocellular carcinoma","volume":"13","author":"Li","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2025.10.005_bib109","first-page":"4058","article-title":"Role of bile acids in the diagnosis and progression of liver cirrhosis: a prospective observational study","volume":"18","author":"Liu","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.livres.2025.10.005_bib110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/jcm8101736","article-title":"Normal alpha-fetoprotein hepatocellular carcinoma: are they really normal?","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.livres.2025.10.005_bib111","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cgh.2011.07.026","article-title":"Level of \u03b1-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma","volume":"9","author":"Tyson","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib112","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3892\/etm.2012.709","article-title":"Relationship of \u03b1-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis","volume":"4","author":"Taura","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.livres.2025.10.005_bib113","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.10.005_bib114","article-title":"Enhanced production of eicosanoids in plasma and activation of DNA damage pathways in PBMCs are correlated with the severity of ancestral COVID-19 infection","author":"Tomalka","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.livres.2025.10.005_bib115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/hep-2016-0012","article-title":"Dysregulated fatty acid metabolism in hepatocellular carcinoma","volume":"3","author":"Wang","year":"2016","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib116","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.livres.2025.10.005_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.778890","article-title":"Elevated Serum uric acid is associated with poor survival in advanced HCC patients and febuxostat improves prognosis in HCC rats","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.10.005_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147263","article-title":"Prognosis-related metabolic genes in the development of colorectal cancer progress and perspective","volume":"862","author":"Miao","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.livres.2025.10.005_bib119","series-title":"StatPearls","article-title":"Physiology, urea cycle","author":"Barmore","year":"2023"},{"key":"10.1016\/j.livres.2025.10.005_bib120","article-title":"A novel purine and uric metabolism signature predicting the prognosis of hepatocellular carcinoma","volume":"13","author":"Yang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.livres.2025.10.005_bib121","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1078-0432.CCR-17-1707","article-title":"Global metabolic profiling identifies a pivotal role of proline and hydroxyproline metabolism in supporting hypoxic response in hepatocellular carcinoma","volume":"24","author":"Tang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.livres.2025.10.005_bib122","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41420-020-00341-8","article-title":"The Janus-like role of proline metabolism in cancer","volume":"6","author":"Burke","year":"2020","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.livres.2025.10.005_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.572663","article-title":"Lysine acetylome study of human hepatocellular carcinoma tissues for biomarkers and therapeutic targets discovery","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.livres.2025.10.005_bib124","doi-asserted-by":"crossref","first-page":"55789","DOI":"10.18632\/oncotarget.10048","article-title":"The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target","volume":"7","author":"Di Martile","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.livres.2025.10.005_bib125","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1021\/jm901220m","article-title":"Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes","volume":"52","author":"Karver","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.livres.2025.10.005_bib126","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10555-008-9113-3","article-title":"Targeting PTPs with small molecule inhibitors in cancer treatment","volume":"27","author":"Jiang","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.livres.2025.10.005_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.999001","article-title":"Human gut microbiota in health and disease: unveiling the relationship","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.livres.2025.10.005_bib128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.livres.2025.10.005_bib129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.hlife.2025.01.001","article-title":"The crucial function of gut microbiota on gut-liver repair","volume":"3","author":"Wang","year":"2025","journal-title":"hLife"},{"key":"10.1016\/j.livres.2025.10.005_bib130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2020.01.002","article-title":"Gut microbiota: a new piece in understanding hepatocarcinogenesis","volume":"474","author":"Zhou","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.livres.2025.10.005_bib131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s10020-024-00830-x","article-title":"The gut microbiota-bile acid axis in cholestatic liver disease","volume":"30","author":"Sun","year":"2024","journal-title":"Mol Med"},{"key":"10.1016\/j.livres.2025.10.005_bib132","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.livres.2025.10.005_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101128","article-title":"Microbial molecules, metabolites, and malignancy","volume":"60","author":"Thomas","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.livres.2025.10.005_bib134","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases","volume":"26","author":"An","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.livres.2025.10.005_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114620","article-title":"Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases","volume":"162","author":"Rasouli-Saravani","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2025.10.005_bib136","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.livres.2025.10.005_bib137","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2240031","article-title":"Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions","volume":"15","author":"Rajapakse","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.livres.2025.10.005_bib138","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/19490976.2020.1764309","article-title":"Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics","volume":"11","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.livres.2025.10.005_bib139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43066-023-00306-3","article-title":"Latest advances in hepatocellular carcinoma management and prevention through advanced technologies","volume":"14","author":"Addissouky","year":"2024","journal-title":"Egyptian Liver Journal"},{"key":"10.1016\/j.livres.2025.10.005_bib140","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.3390\/ijms24087463","article-title":"Metabolic reprogramming of HCC: a new microenvironment for immune responses","volume":"24","author":"Foglia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.10.005_bib141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/carcin\/bgx007","article-title":"Microbiota, NASH, HCC and the potential role of probiotics","volume":"38","author":"Brandi","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.livres.2025.10.005_bib142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In vivo and in vitro models to study liver fibrosis: mechanisms and limitations","volume":"16","author":"Lee","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1536854","article-title":"Organoids and spheroids: advanced in vitro models for liver cancer research","volume":"12","author":"Pastore","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.livres.2025.10.005_bib144","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12551-024-01260-z","article-title":"Computational and experimental advances in liver-on-a-chip technology for cancer research: a systematic review","volume":"17","author":"Carvalho","year":"2024","journal-title":"Biophys Rev"},{"key":"10.1016\/j.livres.2025.10.005_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102418","article-title":"Preclinical human and murine models of hepatocellular carcinoma (HCC)","volume":"48","author":"Sundi","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.livres.2025.10.005_bib146","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.gendis.2020.01.016","article-title":"The fuel and engine: the roles of reprogrammed metabolism in metastasis of primary liver cancer","volume":"7","author":"Zhu","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.livres.2025.10.005_bib147","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.livres.2025.10.005_bib148","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737159.8.5.617","article-title":"Metabolomics-based methods for early disease diagnostics","volume":"8","author":"Gowda","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.livres.2025.10.005_bib149","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3350\/cmh.2024.0348","article-title":"Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine: editorial on \u201cMultiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma\u201d","volume":"30","author":"Ahn","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nrclinonc.2015.103","article-title":"Advances in targeted therapies for hepatocellular carcinoma in the genomic era","volume":"12","author":"Llovet","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.livres.2025.10.005_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1731","article-title":"Harnessing CD8+ T cell dynamics in hepatitis B virus-associated liver diseases: insights, therapies and future directions","volume":"14","author":"Yue","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.livres.2025.10.005_bib152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3727\/105221616X693855","article-title":"Sorafenib and 2-deoxyglucose synergistically inhibit proliferation of both sorafenib-sensitive and -resistant hcc cells by inhibiting ATP production","volume":"17","author":"Reyes","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.livres.2025.10.005_bib153","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2025.10.005_bib154","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.livres.2025.10.005_bib155","first-page":"1","article-title":"Metabolic alterations and vulnerabilities in hepatocellular carcinoma","volume":"9","author":"Tenen","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.livres.2025.10.005_bib156","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.livres.2025.10.005_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/srep18175","article-title":"Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma","volume":"5","author":"Gao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2025.10.005_bib158","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.15419\/bmrat.v9i8.757","article-title":"Dysregulated metabolism in cancer","volume":"9","author":"Isa","year":"2022","journal-title":"Biomedical Research and Therapy"},{"key":"10.1016\/j.livres.2025.10.005_bib159","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.29561","article-title":"A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma","volume":"67","author":"Luo","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.10.005_bib160","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4254\/wjh.v7.i26.2664","article-title":"Challenges of liver cancer: future emerging tools in imaging and urinary biomarkers","volume":"7","author":"Trovato","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2025.10.005_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-97641-9","article-title":"Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma","volume":"15","author":"Prajumwongs","year":"2025","journal-title":"Sci Rep"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:23:53Z","timestamp":1773937433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568425000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":161,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2542568425000704"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2025.10.005","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolites involvement in the growth and spread of liver cancer","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}